Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Medulloblastoma 2Glioma 2Diffuse Intrinsic Pontine Glioma 2Brain Neoplasms 2Xanthomatosis, Cerebrotendinous 1Oligodendroglioma 1Melanoma 1Influenza, Human 1Advanced Fallopian Tube Carcinoma 1

Interventions

Temozolomide 43Magnetic Resonance Spectroscopy 41Radiotherapy 23Specimen Handling 18Biopsy 13X-Rays 10Radiation 10trametinib 8Bevacizumab 8Nivolumab 7Blood Specimen Collection 7olaparib 6fluorodopa F 18 6dabrafenib 6Radiotherapy, Intensity-Modulated 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Lomustine 6pembrolizumab 5abemaciclib 5Standard of Care 5vorasidenib 4ulixertinib 4larotrectinib 4ivosidenib 4erdafitinib 4Surgical Procedures, Operative 4Dianhydrogalactitol 4Cyclophosphamide 4Aminolevulinic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × Diphtheria-Tetanus Vaccine × 1 year × Clear all
NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT03334305 2026-04-23

ACTION

University of Florida

Phase 1 Terminated
18 enrolled 11 charts
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡